Legumain

Legumain Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (1)Mouse (1)

  • Tag

    His Tag (2)

  • Conjugate

    Unconjugated (2)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
LEN-H52H3
Human
HEK293
Human Legumain Protein, His Tag (Pro-form)
LEN-M52H3
Mouse
HEK293
Mouse Legumain Protein, His Tag (Pro-form, HPLC verified)
Total: 2
  • 1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Mouse nerve growth factor (Sinobioway Biomedicine)Phase 3 ClinicalSinobioway Biomedicine Co LtdDiabetic Foot; Optic Nerve Injuries
Details
Choroid plexus cell replacement therapy (Living Cell Technologies)Phase 3 ClinicalLiving Cell TechnologiesSurgical Wound Infection
Details
Recombinant human nerve growth factor (Sichuan ZehaTimes Pharmaceutical)Phase 2 ClinicalSichuan ZehaTimes Pharmaceutical Co LtdOptic Nerve Injuries
Details
Recombinant human nerve growth factor(Sinobioway Biomedicine)SMR001; SMR-001Phase 2 ClinicalSinobioway Biomedicine Co LtdXerophthalmia
Details
Recombinant human nerve growth factor (Xintrum Pharmacouticals)rh-NGFPhase 2 ClinicalJiangsu Zhongxin Pharmaceutical Co LtdKeratitis; Optic Nerve Injuries; Glaucoma, Open-Angle
Details
CHF-6467CHF-6467Phase 2 ClinicalChiesi Farmaceutici SPADiabetic Foot
Details
UdonitrectagREC-0559; MT-8; REC 0/0559Phase 2 ClinicalMimetech SRLKeratitis
Details
Recombinant human nerve growth factor(Chongqing Kerun Biologic)Phase 1 ClinicalKeratitis
Details
CD4^LVFOXP3 Treg-like cell therapyCD4^LVFOXP3Phase 1 ClinicalStanford UniversityPolyendocrinopathies, Autoimmune
Details
Beta-Nerve Growth Factor, Human (Aalborg University)Phase 1 ClinicalAalborg University Shakespeare CompanyPain; Hyperalgesia
Details
Recombinant human nerve growth factor (Beijing Tongren Hospital)Phase 1 ClinicalBeijing Tongren Hospital, CmuOptic Nerve Injuries
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
CenegerminrhNGF (Dompe Farmaceutici)ApprovedDompe Farmaceutici Spa欧适维, Sentinel, OxervateEUKeratitisDompé Pharmaceutici Spa2017-07-06Keratitis; Corneal Ulcer; Corneal Diseases; Dry Eye Syndromes; Retinitis Pigmentosa; Eye Diseases; Nervous System Diseases
Details
Mouse nerve growth factor (Wuhan Hiteck Bio-pharmaceutical)ApprovedWuhan Hiteck Biological Pharma Co Ltd金路捷Mainland ChinaTrauma, Nervous SystemWuhan Hiteck Biological Pharma Co Ltd2002-01-01Optic Nerve Injuries; Trauma, Nervous System
Details
Mouse nerve growth factor (Livzon Group)ApprovedLivzon Pharmaceutical Group Inc丽康乐Mainland ChinaOptic Nerve InjuriesLivzon(Group) Pharmaceutical Factory2010-05-07Optic Nerve Injuries
Details
Mouse nerve growth factor (Staidson Biopharma)Approved苏肽生Mainland ChinaOptic Nerve InjuriesStaidson(Beijing) Biopharmaceuticals Co Ltd2006-04-11Diabetic Foot; Optic Nerve Injuries; Peripheral Nerve Injuries
Details
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland